Molecular elevation of insulin receptor signaling improves memory recall in aged Fischer 344 rats.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
10 2020
Historique:
received: 01 05 2020
revised: 16 07 2020
accepted: 22 07 2020
pubmed: 28 8 2020
medline: 27 8 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

As demonstrated by increased hippocampal insulin receptor density following learning in animal models and decreased insulin signaling, receptor density, and memory decline in aging and Alzheimer's diseases, numerous studies have emphasized the importance of insulin in learning and memory processes. This has been further supported by work showing that intranasal delivery of insulin can enhance insulin receptor signaling, alter cerebral blood flow, and improve memory recall. Additionally, inhibition of insulin receptor function or expression using molecular techniques has been associated with reduced learning. Here, we sought a different approach to increase insulin receptor activity without the need for administering the ligand. A constitutively active, modified human insulin receptor (IRβ) was delivered to the hippocampus of young (2 months) and aged (18 months) male Fischer 344 rats in vivo. The impact of increasing hippocampal insulin receptor expression was investigated using several outcome measures, including Morris water maze and ambulatory gait performance, immunofluorescence, immunohistochemistry, and Western immunoblotting. In aged animals, the IRβ construct was associated with enhanced performance on the Morris water maze task, suggesting that this receptor was able to improve memory recall. Additionally, in both age-groups, a reduced stride length was noted in IRβ-treated animals along with elevated hippocampal insulin receptor levels. These results provide new insights into the potential impact of increasing neuronal insulin signaling in the hippocampus of aged animals and support the efficacy of molecularly elevating insulin receptor activity in vivo in the absence of the ligand to directly study this process.

Identifiants

pubmed: 32852134
doi: 10.1111/acel.13220
pmc: PMC7576226
doi:

Substances chimiques

Receptor, Insulin EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13220

Subventions

Organisme : NIA NIH HHS
ID : T32 AG057461
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32/DK007778
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG027297
Pays : United States
Organisme : NIA NIH HHS
ID : R01/AG033649
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG033649
Pays : United States
Organisme : NIA NIH HHS
ID : T32/AG057461
Pays : United States

Informations de copyright

© 2020 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Références

Neuroscience. 2017 Nov 19;364:130-142
pubmed: 28939258
Am J Physiol Heart Circ Physiol. 2013 Jun 1;304(11):H1538-46
pubmed: 23542919
J Neurosci. 2014 Aug 20;34(34):11188-98
pubmed: 25143600
Behav Brain Res. 2018 Feb 15;338:32-39
pubmed: 28943428
Physiol Behav. 2000 Feb;68(4):509-14
pubmed: 10713291
J Gerontol A Biol Sci Med Sci. 2017 Feb;72(2):189-197
pubmed: 27069097
J Nutr Health Aging. 2013 Mar;17(3):235-9
pubmed: 23459976
Eur J Pharmacol. 2002 Apr 19;441(1-2):1-14
pubmed: 12007915
Neurosci Lett. 2017 Nov 1;660:122-129
pubmed: 28917981
Neuroscience. 1997 Oct;80(4):1033-40
pubmed: 9284058
Diabetes. 2010 Jun;59(6):1521-7
pubmed: 20299468
Biochem Biophys Res Commun. 2017 Feb 19;483(4):981-987
pubmed: 27553276
J Neurosci. 2017 Jun 21;37(25):6132-6148
pubmed: 28559377
Front Neurosci. 2019 Jun 04;13:521
pubmed: 31213970
Neurochem Res. 2019 Jan;44(1):269-280
pubmed: 29572644
Neurosci Biobehav Rev. 2017 Mar;74(Pt A):149-162
pubmed: 28115194
J Neurosci. 2014 Sep 3;34(36):11929-47
pubmed: 25186741
Behav Neurosci. 2003 Oct;117(5):1044-53
pubmed: 14570553
Neuroreport. 2001 Apr 17;12(5):947-51
pubmed: 11303766
BMC Neurosci. 2008 Dec 10;9 Suppl 3:S5
pubmed: 19091002
PLoS One. 2012;7(2):e31124
pubmed: 22383997
J Clin Invest. 2018 Jul 2;128(7):2914-2926
pubmed: 29664737
Exp Neurol. 2019 Mar;313:79-87
pubmed: 30576640
Mol Neurobiol. 2017 Oct;54(8):6507-6522
pubmed: 27730514
J Gerontol A Biol Sci Med Sci. 2016 Jan;71(1):30-9
pubmed: 25659889
Eur J Pharmacol. 2013 Nov 5;719(1-3):34-43
pubmed: 23872402
CNS Drugs. 2013 Jul;27(7):505-14
pubmed: 23719722
J Biol Chem. 1991 Jan 5;266(1):386-90
pubmed: 1845969
Diabetes Metab Res Rev. 2015 Jan;31(1):1-13
pubmed: 24464982
Front Neurosci. 2020 Jul 07;14:668
pubmed: 32733189
Mol Neurobiol. 2019 Apr;56(4):2922-2943
pubmed: 30073505
J Neurochem. 2014 Dec;131(5):582-7
pubmed: 25230927
Eur J Pharmacol. 2004 Apr 19;490(1-3):71-81
pubmed: 15094074
J Alzheimers Dis. 2015;47(3):715-28
pubmed: 26401706
Diabetes. 2015 Nov;64(11):3927-36
pubmed: 26216852
Science. 2000 Sep 22;289(5487):2122-5
pubmed: 11000114
J Biol Chem. 1999 Dec 3;274(49):34893-902
pubmed: 10574963
J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1021-1030
pubmed: 31180116
Neurosci Lett. 2014 Jul 25;576:73-8
pubmed: 24882721
Brain Res. 2009 Nov 3;1296:35-45
pubmed: 19679110
J Cereb Blood Flow Metab. 2017 Sep;37(9):3203-3218
pubmed: 28058996
Cell. 2016 Aug 11;166(4):867-880
pubmed: 27518562
Adv Drug Deliv Rev. 2012 May 15;64(7):614-28
pubmed: 22119441
Prog Neurobiol. 1991;36(5):343-62
pubmed: 1887067
Am J Physiol. 1983 Sep;245(3):C283-7
pubmed: 6351631
Diabet Med. 2011 Dec;28(12):1463-75
pubmed: 21974744
J Neurosci. 2016 Oct 12;36(41):10683-10695
pubmed: 27733618
Neurobiol Aging. 2013 Aug;34(8):1977-87
pubmed: 23545425
Science. 2014 Feb 21;343(6173):857-63
pubmed: 24558155
Exp Neurol. 2006 Mar;198(1):48-53
pubmed: 16337941
Exp Neurol. 2014 Nov;261:610-9
pubmed: 24918340

Auteurs

Hilaree N Frazier (HN)

Department of Pharmacology and Nutritional Sciences, Lexington, Kentucky, USA.

Katie L Anderson (KL)

Department of Pharmacology and Nutritional Sciences, Lexington, Kentucky, USA.

Adam O Ghoweri (AO)

Department of Pharmacology and Nutritional Sciences, Lexington, Kentucky, USA.

Ruei-Lung Lin (RL)

Department of Pharmacology and Nutritional Sciences, Lexington, Kentucky, USA.

Tara R Hawkinson (TR)

Department of Pharmacology and Nutritional Sciences, Lexington, Kentucky, USA.

Gabriel J Popa (GJ)

Department of Molecular and Cellular Biochemistry, Lexington, Kentucky, USA.

Pradoldej Sompol (P)

Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.

Michael D Mendenhall (MD)

Department of Molecular and Cellular Biochemistry, Lexington, Kentucky, USA.

Christopher M Norris (CM)

Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.

Olivier Thibault (O)

Department of Pharmacology and Nutritional Sciences, Lexington, Kentucky, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH